Posterior reversible encephalopathy syndrome (PRES) is a neurotoxic state with distinct clinical and radiological features. It is characterized by headache, vomiting, altered mentality, seizures, and visual disturbances. PRES typically consists of reversible vasogenic edema in the posterior circulation territories, although irreversible cytotoxic edema and atypical lesion locations have also been described. Most patients are markedly hypertensive at presentation, although some have only mildly elevated or even normal blood pressure. Many known causative factors of PRES have been elucidated, but its underlying pathophysiology remains poorly defined. This review summarizes the etiologies, presumed pathophysiology, histopathologic findings, basic and advanced imaging features, clinical symptoms of presentation, and treatment of PRES. 
PRES-related conditions cause the activation of the immune system and the release of cytokines such as TNF-a and IL-1. TNF-a and IL-1 induce the expression of the adhesion molecules ICAM-1 and VCAM-1 which interact with leukocytes, making them produce ROS and proteases leading to endothelial damage and consequent fluid leakage. TNF-a and IL-1 can also induce astrocytes production of VEGF which weakens the tight junction of brain vasculature and activates the VVO, thus contributing to edema formation (This figure was kindly provided by Dr. Marra A 
